mayo clinic glp-1 program GLP-1s and Aging: Risks, Benefits & Weight Loss After 60 Beyond Ozempic: The GLP-1 boom
Description
Preparing for the Program Patients should take the following steps beginning July 1: 1
How Nutrition Changes When Taking GLP-1 Medications This is where nutrition stops being secondary and becomes a central part of treatment
Whats more, over a dozen potential new GLP-1 RAs are being developed [archived link]
It is a GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist
They inhibit an enzyme called DPP-IV, which can cause the body to function differently, potentially affecting how tumors develop and spread
doi: 10.1016/S0140-6736(21)01324-6 Summary Keywords glucagon, GLP-1, obesity, co-agonist, weight loss Citation Hope DCD, Vincent ML and Tan TMM (2021) Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity
